4PKB.F Stock Analysis
4P
Uncovered
LAVA Therapeutics NV is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
-23/100
Low score
LAVA Therapeutics NV operates as an immuno-oncology company. The company is headquartered in Utrecht, Utrecht and currently employs 55 full-time employees. The company went IPO on 2021-03-29. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
View Section: Eyestock Rating